Europe — EMA
Olanzapine Glenmark
Olanzapine, the active ingredient in Olanzapine Glenmark, is an atypical antipsychotic presented as a unknown/unknown for oral use. It treats schizophrenia and bipolar disorder in adults and adolescents.
Request sourcing
What is Olanzapine?
Olanzapine, the active ingredient in Olanzapine Glenmark, is an atypical antipsychotic presented as a unknown/unknown for oral use. It treats schizophrenia and bipolar disorder in adults and adolescents. GNH USA supplies Olanzapine Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Olanzapine Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olanzapine used for?
Olanzapine Glenmark is an atypical antipsychotic that modulates the dopamine and serotonin pathways involved in serious mental health disorders.
- Schizophrenia: Improves psychotic symptoms such as delusions and hallucinations. - Bipolar I disorder: Helps to stabilize mood and reduce manic episodes. - Acute psychotic episodes: Provides rapid symptom control during severe episodes. - Maintenance therapy : Supports long‑term relapse‑preventive treatment. - Adjacent … … … … … - … ... … … ... … … … … ... "
